Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis B.

[1]  A. Craxì,et al.  Anti-alpha interferon antibodies after alpha interferon treatment in patients with chronic viral hepatitis. , 1988, Hepato-Gastroenterology.

[2]  J. Hoofnagle,et al.  Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B , 1988 .

[3]  A. Lok,et al.  LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION , 1988, The Lancet.

[4]  Ching-lung Lai,et al.  PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDREN , 1987, The Lancet.

[5]  Heather M. Smith,et al.  Loss of HBsAg with interferon‐α therapy in chronic hepatitis D virus infection , 1993, Journal of medical virology.

[6]  J. Harris,et al.  Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV‐III antibodies to recombinant α‐interferon , 1987, Hepatology.

[7]  A. Lok,et al.  Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. , 1987, Gastroenterology.

[8]  J. Gutterman,et al.  Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa‐2a by intramuscular injection , 1987, Cancer.

[9]  G. Fattovich,et al.  Changes in serum hepatitis B virus (HBV) DNA positivity in chronic HBV infection: results of a long-term follow-up study of 138 patients. , 1986, The Journal of infectious diseases.

[10]  J. Hoofnagle,et al.  Interferon in viral hepatitis: Role in pathogenesis and treatment , 1986, Hepatology.

[11]  M. Rugge,et al.  Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti‐HBe in chronic hepatitis type B , 1986, Hepatology.

[12]  A. Dibisceglie,et al.  Recombinant leukocyte interferon treatment of chronic hepatitis B , 1985, Hepatology.

[13]  A. Lok,et al.  Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease. , 1985, Journal of hepatology.

[14]  H. Thomas,et al.  Antiviral Treatment of Chronic Hepatitis B Virus Infection , 1984, Journal of the Royal Society of Medicine.

[15]  C. Chu,et al.  Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis. , 1983, Gastroenterology.

[16]  J. Hoofnagle,et al.  Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. , 1981, Annals of internal medicine.

[17]  T. Merigan,et al.  Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. , 1981, The Journal of infectious diseases.

[18]  M. Rugge,et al.  Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection , 1980 .